Thomas J. Garrity

Thomas J. Garrity (board member) discloses dealings in Antares Pharma, Inc. to SEC (Form 4). The record holds 72 filings, for trades running from 18 March 2011 to 24 May 2022.

In open-market terms, that means 4 purchases worth €38k on one side and 11 sales worth €1.3M on the other. Sales outweigh purchases by €1.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 25 share grants and 30 option exercises.

A typical purchase (the median) is worth €7,639.

On 26 May 2022 came the latest disclosure, a transaction for €133k in Antares Pharma, Inc. The last purchase on record was published on 21 March 2016, which is 3,868 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.